(Q38003075)

26 August 2017

title

The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management (English)

1 reference

26 August 2017

1

James O Armitage

1 reference

26 August 2017

language of work or name

1 reference

1 May 2012

1 reference

American Journal of Hematology

26 August 2017

published in

1 reference

26 August 2017

volume

87

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

511-519

1 reference

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

26 August 2017

cites work

1 reference

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

21 January 2018

1 reference

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations

21 January 2018

1 reference

Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma

21 January 2018

1 reference

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas

21 January 2018

1 reference

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

21 January 2018

1 reference

Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies

21 January 2018

1 reference

F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas

21 January 2018

1 reference

Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.

21 January 2018

1 reference

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group.

21 January 2018

1 reference

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials

21 January 2018

1 reference

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

21 January 2018

1 reference

Intestinal lymphoma associated with malabsorption

21 January 2018

1 reference

Risk of malignancy in patients with celiac disease.

21 January 2018

1 reference

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

21 January 2018

1 reference

Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology

21 January 2018

1 reference

Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review

21 January 2018

1 reference

Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation

21 January 2018

1 reference

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

21 January 2018

1 reference

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

21 January 2018

1 reference

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology

21 January 2018

1 reference

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

21 January 2018

1 reference

Crizotinib in anaplastic large-cell lymphoma

21 January 2018

1 reference

Stem-cell transplantation in T-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

Anaplastic large-cell lymphoma in women with breast implants

21 January 2018

1 reference

Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group

21 January 2018

1 reference

Advances in the understanding and management of angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

21 January 2018

1 reference

Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

21 January 2018

1 reference

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

21 January 2018

1 reference

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

21 January 2018

1 reference

L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

21 January 2018

1 reference

Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation

21 January 2018

1 reference

Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

21 January 2018

1 reference

Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine

21 January 2018

1 reference

2'-Deoxycoformycin for hepatosplenic gammadelta T-cell lymphoma

21 January 2018

1 reference

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.23144

1 reference

26 August 2017

1 reference